GENERATOR HEART FAILURE DataMart: An integrated framework for heart failure research.
artificial intelligence
big data
datamart
heart failure
machine learning
Journal
Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388
Informations de publication
Date de publication:
2023
2023
Historique:
received:
21
11
2022
accepted:
07
03
2023
medline:
11
4
2023
entrez:
10
4
2023
pubmed:
11
4
2023
Statut:
epublish
Résumé
Heart failure (HF) is a multifaceted clinical syndrome characterized by different etiologies, risk factors, comorbidities, and a heterogeneous clinical course. The current model, based on data from clinical trials, is limited by the biases related to a highly-selected sample in a protected environment, constraining the applicability of evidence in the real-world scenario. If properly leveraged, the enormous amount of data from real-world may have a groundbreaking impact on clinical care pathways. We present, here, the development of an HF DataMart framework for the management of clinical and research processes. Within our institution, Fondazione Policlinico Universitario A. Gemelli in Rome (Italy), a digital platform dedicated to HF patients has been envisioned (GENERATOR HF DataMart), based on two building blocks: 1. All retrospective information has been integrated into a multimodal, longitudinal data repository, providing in one single place the description of individual patients with drill-down functionalities in multiple dimensions. This functionality might allow investigators to dynamically filter subsets of patient populations characterized by demographic characteristics, biomarkers, comorbidities, and clinical events (e.g., re-hospitalization), enabling agile analyses of the outcomes by subsets of patients. 2. With respect to expected long-term health status and response to treatments, the use of the disease trajectory toolset and predictive models for the evolution of HF has been implemented. The methodological scaffolding has been constructed in respect of a set of the preferred standards recommended by the CODE-EHR framework. Several examples of GENERATOR HF DataMart utilization are presented as follows: to select a specific retrospective cohort of HF patients within a particular period, along with their clinical and laboratory data, to explore multiple associations between clinical and laboratory data, as well as to identify a potential cohort for enrollment in future studies; to create a multi-parametric predictive models of early re-hospitalization after discharge; to cluster patients according to their ejection fraction (EF) variation, investigating its potential impact on hospital admissions. The GENERATOR HF DataMart has been developed to exploit a large amount of data from patients with HF from our institution and generate evidence from real-world data. The two components of the HF platform might provide the infrastructural basis for a combined patient support program dedicated to continuous monitoring and remote care, assisting patients, caregivers, and healthcare professionals.
Sections du résumé
Background
UNASSIGNED
Heart failure (HF) is a multifaceted clinical syndrome characterized by different etiologies, risk factors, comorbidities, and a heterogeneous clinical course. The current model, based on data from clinical trials, is limited by the biases related to a highly-selected sample in a protected environment, constraining the applicability of evidence in the real-world scenario. If properly leveraged, the enormous amount of data from real-world may have a groundbreaking impact on clinical care pathways. We present, here, the development of an HF DataMart framework for the management of clinical and research processes.
Methods
UNASSIGNED
Within our institution, Fondazione Policlinico Universitario A. Gemelli in Rome (Italy), a digital platform dedicated to HF patients has been envisioned (GENERATOR HF DataMart), based on two building blocks: 1. All retrospective information has been integrated into a multimodal, longitudinal data repository, providing in one single place the description of individual patients with drill-down functionalities in multiple dimensions. This functionality might allow investigators to dynamically filter subsets of patient populations characterized by demographic characteristics, biomarkers, comorbidities, and clinical events (e.g., re-hospitalization), enabling agile analyses of the outcomes by subsets of patients. 2. With respect to expected long-term health status and response to treatments, the use of the disease trajectory toolset and predictive models for the evolution of HF has been implemented. The methodological scaffolding has been constructed in respect of a set of the preferred standards recommended by the CODE-EHR framework.
Results
UNASSIGNED
Several examples of GENERATOR HF DataMart utilization are presented as follows: to select a specific retrospective cohort of HF patients within a particular period, along with their clinical and laboratory data, to explore multiple associations between clinical and laboratory data, as well as to identify a potential cohort for enrollment in future studies; to create a multi-parametric predictive models of early re-hospitalization after discharge; to cluster patients according to their ejection fraction (EF) variation, investigating its potential impact on hospital admissions.
Conclusion
UNASSIGNED
The GENERATOR HF DataMart has been developed to exploit a large amount of data from patients with HF from our institution and generate evidence from real-world data. The two components of the HF platform might provide the infrastructural basis for a combined patient support program dedicated to continuous monitoring and remote care, assisting patients, caregivers, and healthcare professionals.
Identifiants
pubmed: 37034335
doi: 10.3389/fcvm.2023.1104699
pmc: PMC10073733
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1104699Informations de copyright
© 2023 D'Amario, Laborante, Delvinoti, Lenkowicz, Iacomini, Masciocchi, Luraschi, Damiani, Rodolico, Restivo, Ciliberti, Paglianiti, Canonico, Paternello, Cesario, Valentini, Scambia and Crea.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Eur J Heart Fail. 2017 Dec;19(12):1615-1623
pubmed: 28387002
Eur Heart J. 2020 Dec 21;41(48):4556-4564
pubmed: 32128588
Eur Heart J. 2022 Oct 7;43(37):3578-3588
pubmed: 36208161
J Card Fail. 2017 Dec;23(12):868-875
pubmed: 29029965
Front Cardiovasc Med. 2022 Oct 31;9:1009475
pubmed: 36386309
Curr Heart Fail Rep. 2020 Oct;17(5):213-224
pubmed: 32783147
Radiother Oncol. 2020 Mar;144:189-200
pubmed: 31911366
Front Cardiovasc Med. 2022 Apr 01;9:844296
pubmed: 35433868
JMIR Med Inform. 2021 Jul 30;9(7):e21929
pubmed: 34328424
Cluster Comput. 2022 Aug 17;:1-41
pubmed: 35996680
Curr Opin Cardiol. 2022 Jan 1;37(1):130-136
pubmed: 34857721
Eur Heart J. 2021 Sep 21;42(36):3599-3726
pubmed: 34447992
Lancet. 2018 Feb 10;391(10120):572-580
pubmed: 29174292
J Am Med Inform Assoc. 2019 Nov 1;26(11):1189-1194
pubmed: 31414700
Circ Heart Fail. 2017 Jun;10(6):
pubmed: 28615366
JACC Heart Fail. 2019 Apr;7(4):306-317
pubmed: 30852236
Sci Data. 2016 Mar 15;3:160018
pubmed: 26978244
Cardiol J. 2018;25(3):353-362
pubmed: 28980289
Sci Rep. 2023 Jan 6;13(1):294
pubmed: 36609415
Nat Med. 2023 Jan;29(1):49-58
pubmed: 36646803
Heart. 2020 Mar;106(5):399-400
pubmed: 31974212
Circ Heart Fail. 2012 Nov;5(6):720-6
pubmed: 22936826
Eur Heart J. 2017 Jun 21;38(24):1865-1867
pubmed: 28863461
Eur Heart J. 2019 Jul 1;40(25):2058-2073
pubmed: 30815669
J Pers Med. 2021 Jan 22;11(2):
pubmed: 33498985
ESC Heart Fail. 2018 Feb;5(1):9-18
pubmed: 29385659
Circulation. 2014 Jun 10;129(23):2380-7
pubmed: 24799515
Nat Med. 2019 Jan;25(1):44-56
pubmed: 30617339
Environ Int. 2022 Jul;165:107334
pubmed: 35696847
Eur Heart J. 2019 Dec 14;40(47):3859-3868c
pubmed: 31800034
Methodist Debakey Cardiovasc J. 2020 Jul-Sep;16(3):205-211
pubmed: 33133356
Eur J Heart Fail. 2022 May;24(5):871-884
pubmed: 35257446
J Am Coll Cardiol. 2018 Jul 24;72(4):351-366
pubmed: 30025570
Curr Heart Fail Rep. 2017 Apr;14(2):59-70
pubmed: 28247180
N Engl J Med. 2016 Dec 8;375(23):2293-2297
pubmed: 27959688